STOP-HF: Gene therapy SDF-1 remodels hearts of high risk heart ...
HealthCanal.com
Dr Penn, a cardiologist at Summa Cardiovascular Institute in Akron, Ohio, US, stated that based on the literature the degree of heart remodelling induced by SDF-1 over-expression should give a greater than 80% chance of mortality benefit in future trials.

y más »